174 related articles for article (PubMed ID: 34914893)
21. Inactivating hepatic follistatin alleviates hyperglycemia.
Tao R; Wang C; Stöhr O; Qiu W; Hu Y; Miao J; Dong XC; Leng S; Stefater M; Stylopoulos N; Lin L; Copps KD; White MF
Nat Med; 2018 Jul; 24(7):1058-1069. PubMed ID: 29867232
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.
Altomonte J; Richter A; Harbaran S; Suriawinata J; Nakae J; Thung SN; Meseck M; Accili D; Dong H
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E718-28. PubMed ID: 12783775
[TBL] [Abstract][Full Text] [Related]
23. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
[TBL] [Abstract][Full Text] [Related]
24. FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization.
O-Sullivan I; Zhang W; Wasserman DH; Liew CW; Liu J; Paik J; DePinho RA; Stolz DB; Kahn CR; Schwartz MW; Unterman TG
Nat Commun; 2015 May; 6():7079. PubMed ID: 25963540
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA Gomafu upregulates Foxo1 expression to promote hepatic insulin resistance by sponging miR-139-5p.
Yan C; Li J; Feng S; Li Y; Tan L
Cell Death Dis; 2018 Feb; 9(3):289. PubMed ID: 29459686
[TBL] [Abstract][Full Text] [Related]
26. MAPK phosphatase-3 promotes hepatic gluconeogenesis through dephosphorylation of forkhead box O1 in mice.
Wu Z; Jiao P; Huang X; Feng B; Feng Y; Yang S; Hwang P; Du J; Nie Y; Xiao G; Xu H
J Clin Invest; 2010 Nov; 120(11):3901-11. PubMed ID: 20921625
[TBL] [Abstract][Full Text] [Related]
27. Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1.
Wang S; Ai H; Liu L; Zhang X; Gao F; Zheng L; Yi J; Sun L; Yu C; Zhao H; Li Y
Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E911-E924. PubMed ID: 31526292
[TBL] [Abstract][Full Text] [Related]
28. FOXO1 is downregulated in obese mice subjected to short-term strength training.
Pereira RM; da Cruz Rodrigues KC; Sant'Ana MR; da Rocha AL; Morelli AP; Veras ASC; Gaspar RS; da Costa Fernandes CJ; Teixeira GR; Simabuco FM; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
J Cell Physiol; 2022 Nov; 237(11):4262-4274. PubMed ID: 36125908
[TBL] [Abstract][Full Text] [Related]
29. Oleanolic acid reduces hyperglycemia beyond treatment period with Akt/FoxO1-induced suppression of hepatic gluconeogenesis in type-2 diabetic mice.
Zeng XY; Wang YP; Cantley J; Iseli TJ; Molero JC; Hegarty BD; Kraegen EW; Ye Y; Ye JM
PLoS One; 2012; 7(7):e42115. PubMed ID: 22860063
[TBL] [Abstract][Full Text] [Related]
30. RNA sequencing of db/db mice liver identifies lncRNA H19 as a key regulator of gluconeogenesis and hepatic glucose output.
Goyal N; Sivadas A; Shamsudheen KV; Jayarajan R; Verma A; Sivasubbu S; Scaria V; Datta M
Sci Rep; 2017 Aug; 7(1):8312. PubMed ID: 28814771
[TBL] [Abstract][Full Text] [Related]
31. Prostaglandin F
Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
[TBL] [Abstract][Full Text] [Related]
32. SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding.
Jang H; Lee GY; Selby CP; Lee G; Jeon YG; Lee JH; Cheng KK; Titchenell P; Birnbaum MJ; Xu A; Sancar A; Kim JB
Nat Commun; 2016 Jul; 7():12180. PubMed ID: 27412556
[TBL] [Abstract][Full Text] [Related]
33. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss.
Marinho R; Ropelle ER; Cintra DE; De Souza CT; Da Silva AS; Bertoli FC; Colantonio E; D'Almeida V; Pauli JR
J Cell Physiol; 2012 Jul; 227(7):2917-26. PubMed ID: 21938726
[TBL] [Abstract][Full Text] [Related]
34. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.
Matsumoto M; Pocai A; Rossetti L; Depinho RA; Accili D
Cell Metab; 2007 Sep; 6(3):208-16. PubMed ID: 17767907
[TBL] [Abstract][Full Text] [Related]
35. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
36. IPMK modulates hepatic glucose production and insulin signaling.
Jung IR; Anokye-Danso F; Jin S; Ahima RS; Kim SF
J Cell Physiol; 2022 Aug; 237(8):3421-3432. PubMed ID: 35822903
[TBL] [Abstract][Full Text] [Related]
37. Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production.
Titchenell PM; Quinn WJ; Lu M; Chu Q; Lu W; Li C; Chen H; Monks BR; Chen J; Rabinowitz JD; Birnbaum MJ
Cell Metab; 2016 Jun; 23(6):1154-1166. PubMed ID: 27238637
[TBL] [Abstract][Full Text] [Related]
38. FOXO1 inhibition synergizes with FGF21 to normalize glucose control in diabetic mice.
Lee YK; Diaz B; Deroose M; Lee SX; Belvedere S; Accili D; Leibel RL; Lin HV
Mol Metab; 2021 Jul; 49():101187. PubMed ID: 33577983
[TBL] [Abstract][Full Text] [Related]
39. Acid Loading Unmasks Glucose Homeostatic Instability in Proximal-Tubule-Targeted Insulin/Insulin-Like-Growth-Factor-1 Receptor Dual Knockout Mice.
Aljaylani A; Fluitt M; Piselli A; Shepard BD; Tiwari S; Ecelbarger CM
Cell Physiol Biochem; 2020 Jul; 54(4):682-695. PubMed ID: 32678535
[TBL] [Abstract][Full Text] [Related]
40. DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver.
Tong X; Zhang D; Charney N; Jin E; VanDommelen K; Stamper K; Gupta N; Saldate J; Yin L
Diabetes; 2017 Oct; 66(10):2571-2582. PubMed ID: 28790135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]